Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Initial daily sorafenib dose administered to US patients enrolled in GIDEON by TACE subgroup
| n (%) | No TACE n=318 | Group A Prior TACE n=158 | Group B Concomitant TACE n=29 | Group C Prior and Concomitant TACE n=38 |
|---|---|---|---|---|
| Initial dosea | ||||
| 800 mg/day | 182 (57) | 86 (54) | 14 (48) | 17 (45) |
| 400 mg/day | 109 (34) | 52 (33) | 12 (41) | 14 (37) |
| Otherb | 26 (8) | 20 (13) | 3 (10) | 7 (18) |
Data refer to the safety population (n=563).
Missing for 1 patient.
Other doses included 100, 200, and 600 mg/day.
